For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.
(Reporting by Promit Mukherjee; editing by Jason Neely)
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
224.3 ZAR | +0.52% | +3.48% | +10.21% |
Mar. 08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
Mar. 05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
JOHANNESBURG (Reuters) - South African drugmaker Aspen Pharmacare on Wednesday posted a 4% drop in annual profit impacted by higher inflation and a drop in COVID-19 vaccine sales.
For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.
(Reporting by Promit Mukherjee; editing by Jason Neely)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
224.3 ZAR | +0.52% | +3.48% | 5.31B | ||
144.6 USD | -1.52% | -3.32% | 348B | ||
1st Jan change | Capi. | |
---|---|---|
+10.21% | 5.31B | |
+19.27% | 43.18B | |
+24.05% | 23.23B | |
+15.11% | 14.6B | |
+12.33% | 13.54B | |
+38.36% | 11.5B | |
-7.63% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
-2.27% | 4.81B |